Eversheds Dublin advises Endo Health on $1.7bn takeover of Paladin Labs
The Dublin office of Eversheds has advised on the takeover by Endo Health Solutions of Paladin Labs Europe for approximately $1.7bn (£1.1bn).
The acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target. An inversion is a legal transaction whereby one corporation becomes a subsidiary of another headquartered in a foreign jurisdiction, and as a result the original corporation becomes subject to the tax laws of the foreign jurisdiction instead.
Partners Abigail St John Kennedy, Piaras Power and Darragh Blake and solicitors Darran Nangle and Niamh McMahon from the corporate banking team acted for Endo Health.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
The notion of ‘gross negligence’ is an important matter for customers and institutions alike and has been reviewed by the High Court and Supreme Court in deciding a recent case.
This report includes an analysis of the results of Eversheds survey on the Employment Tribunal process, which is based on 180 responses.
Analysis from The Lawyer
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe
Could Slater & Gordon achieve its stated aim of becoming a top consumer brand by acquiring Pannone?